US Patent Issued to SUMITOMO PHARMA, INTERNATIONAL INSTITUTE OF CANCER IMMUNOLOGY on Aug. 12 for "WT1 helper peptides and combinations of WT1 helper peptide and conjugate of cancer antigen peptides" (Japanese Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,383,608, issued on Aug. 12, was assigned to SUMITOMO PHARMA Co. LTD. (Osaka, Japan) and INTERNATIONAL INSTITUTE OF CANCER IMMUNOLOGY INC. (Suita, Japan).

"WT1 helper peptides and combinations of WT1 helper peptide and conjugate of cancer antigen peptides" was invented by Hitoshi Ban (Nishinomiya, Japan), Masashi Goto (Ibaraki, Japan) and Yosuke Takanashi (Osaka, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present application relates to WT1 helper peptides consisting of an amino acid sequence of 9 to 30 amino acid residues including a sequence: KLSHL as part thereof, and combinations of a WT1 helper peptide and a conjugate of cancer antigen ...